(Q24235194)

English

No label defined

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

0 references

0 references

Safety of non-steroidal anti-inflammatory drugs, including aspirin and paracetamol (acetaminophen) in people receiving methotrexate for inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis) (English)

0 references

0 references

0 references

rheumatoid arthritis

0 references

psoriatic arthritis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

ankylosing spondylitis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Alexandra N Colebatch

1

0 references

Jonathan L Marks

2

0 references

Christopher J Edwards

3

0 references

publication date

9 November 2011

0 references

Cochrane Database of Systematic Reviews

0 references

Pulmonary disease during the treatment of rheumatoid arthritis with low dose pulse methotrexate

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

21 January 2018

Total and free methotrexate pharmacokinetics, with and without piroxicam, in rheumatoid arthritis patients.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

21 January 2018

Thrombocytopenia in patients with rheumatoid arthritis on long-term treatment with low dose methotrexate

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

21 January 2018

Aspirin, hydroxychloroquine, and hepatic enzyme abnormalities with methotrexate in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

21 January 2018

Risk factors associated with the cumulative survival of low-dose methotrexate in 273 Japanese patients with rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

21 January 2018

Examination of the effect of increasing doses of etoricoxib on oral methotrexate pharmacokinetics in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

21 January 2018

Renal effects of aspirin and low dose methotrexate in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

21 January 2018

Urinary excretion of alpha-GST and albumin in rheumatoid arthritis patients treated with methotrexate or other DMARDs alone or in combination with NSAIDs

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

21 January 2018

Clinical investigation of methotrexate in the treatment of ankylosing spondylitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

21 January 2018

Pulmonary involvement in lifelong non-smoking patients with rheumatoid arthritis and ankylosing spondylitis without respiratory symptoms

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

21 January 2018

Efficacy and safety of valdecoxib in treating the signs and symptoms of rheumatoid arthritis: a randomized, controlled comparison with placebo and naproxen

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

21 January 2018

Hematologic malignant neoplasms after drug exposure in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

21 January 2018

Efficacy of methotrexate in the treatment of ankylosing spondylitis: a three-year open study.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

21 January 2018

Rheumatoid arthritis and the risk of malignancy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

21 January 2018

Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

21 January 2018

Elevated liver enzyme tests among patients with rheumatoid arthritis or psoriatic arthritis treated with methotrexate and/or leflunomide

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

21 January 2018

Investigation of the chronic pulmonary effects of low-dose oral methotrexate in patients with rheumatoid arthritis: a prospective study incorporating HRCT scanning and pulmonary function tests.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

21 January 2018

Survival analysis of disease modifying antirheumatic drugs in Spanish rheumatoid arthritis patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

21 January 2018

Systematic review: comparative effectiveness and harms of disease-modifying medications for rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

21 January 2018

Use of short-term efficacy/toxicity tradeoffs to select second-line drugs in rheumatoid arthritis. A metaanalysis of published clinical trials

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

21 January 2018

Analysis of improvements, full responses, remission and toxicity in rheumatoid patients treated with step-up combination therapy (methotrexate, cyclosporin A, sulphasalazine) or monotherapy for three years

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

21 January 2018

The relative toxicity of disease-modifying antirheumatic drugs

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

21 January 2018

Effect of aspirin and sulindac on methotrexate clearance

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

21 January 2018

Real-world utilization of DMARDs and biologics in rheumatoid arthritis: the RADIUS (Rheumatoid Arthritis Disease-Modifying Anti-Rheumatic Drug Intervention and Utilization Study) study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

21 January 2018

Progressive preclinical interstitial lung disease in rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

21 January 2018

Methotrexate and early postoperative complications in patients with rheumatoid arthritis undergoing elective orthopaedic surgery

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

21 January 2018

Low dose oral methotrexate in rheumatoid arthritis: an uncontrolled trial and review of the literature

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

21 January 2018

No efficacy of subcutaneous methotrexate in active ankylosing spondylitis: a 16-week open-label trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

21 January 2018

Lumiracoxib does not affect methotrexate pharmacokinetics in rheumatoid arthritis patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

21 January 2018

Factors associated with toxicity, final dose, and efficacy of methotrexate in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

21 January 2018

The frequency and clinical characteristics of methotrexate (MTX) oral toxicity in rheumatoid arthritis (RA): a masked and controlled study.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

21 January 2018

Efficacy of SLZ and MTX (alone or combination) on the treatment of active sacroiliitis in early AS.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

21 January 2018

Eosinophilia in rheumatologic diseases: a prospective study of 1000 cases

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

21 January 2018

Long-term application of disease modifying antirheumatic drugs (DMARD). A single-center, observational study of 1681 patients with rheumatoid arthritis (RA).

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

21 January 2018

A prospective study of renal disease in patients with early rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

21 January 2018

Use of nonbiologic disease-modifying antirheumatic drugs and risk of infection in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

21 January 2018

How common is diclofenac-associated liver injury? Analysis of 17,289 arthritis patients in a long-term prospective clinical trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

21 January 2018

Methotrexate-induced pancytopenia: serious and under-reported? Our experience of 25 cases in 5 years

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

21 January 2018

Use of disease-modifying antirheumatic drugs in patients with psoriatic arthritis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

21 January 2018

Herpes zoster risk factors in a national cohort of veterans with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

21 January 2018

Methotrexate in the treatment of rheumatoid arthritis. II. In vivo effects on bone mineral density

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

21 January 2018

Usefulness of actarit in elderly rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

21 January 2018

Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

21 January 2018

Mortality in patients with rheumatoid arthritis treated actively from the time of diagnosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

21 January 2018

Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

21 January 2018

Atheroprotective effects of methotrexate on reverse cholesterol transport proteins and foam cell transformation in human THP-1 monocyte/macrophages

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

21 January 2018

Drugs Used in the Treatment of Rheumatoid Arthritis: Relationship between Current Use and Cardiovascular Risk Factors

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

21 January 2018

Rationale for bone marrow examination in patients with inflammatory rheumatic diseases

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

21 January 2018

Light and electron microscopic analysis of liver biopsy samples from rheumatoid arthritis patients receiving long-term methotrexate therapy.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

21 January 2018

Methotrexate in the treatment of ankylosing spondylitis.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

21 January 2018

The effectiveness of a traditional therapeutical approach in early psoriatic arthritis: results of a pilot randomised 6-month trial with methotrexate.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

21 January 2018

Step-up combination versus switching of non-biological disease-modifying antirheumatic drugs in rheumatoid arthritis: results from a retrospective observational study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

21 January 2018

Lack of pharmacokinetic interaction between rofecoxib and methotrexate in rheumatoid arthritis patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

21 January 2018

The risk of herpes zoster in patients with rheumatoid arthritis in the United States and the United Kingdom

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

21 January 2018

Coadministration of naproxen and low-dose methotrexate in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

21 January 2018

Evaluation of small bowel injury in patients with rheumatoid arthritis by capsule endoscopy: effects of anti-rheumatoid arthritis drugs.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

21 January 2018

Newer disease-modifying antirheumatic drugs and the risk of serious hepatic adverse events in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

21 January 2018

Leflunomide use and the risk of interstitial lung disease in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

21 January 2018

Low-dose methotrexate in rheumatoid arthritis: effect and tolerance. An open trial and a double-blind randomized study.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

21 January 2018

Clinical and pharmacokinetic evidence of a life-threatening interaction between methotrexate and ketoprofen

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

21 January 2018

The effects of a salicylate, ibuprofen, and naproxen on the disposition of methotrexate in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

21 January 2018

Methotrexate disposition following concomitant administration of ketoprofen, piroxicam and flurbiprofen in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

21 January 2018

Termination of disease-modifying antirheumatic drugs in rheumatoid arthritis and in psoriatic arthritis. A comparative study of 270 cases

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

21 January 2018

Coadministration of lansoprazole and naproxen does not affect the pharmacokinetic profile of methotrexate in adult patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

21 January 2018

Purine enzymes in patients with rheumatoid arthritis treated with methotrexate

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

21 January 2018

Toxicity of anti-rheumatic drugs in a randomized clinical trial of early rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

21 January 2018

Methotrexate: long-term safety and efficacy in an Australian consultant rheumatology practice.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

21 January 2018

Polypharmacy among patients admitted to hospital with rheumatic diseases

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

21 January 2018

Nonsteroidal anti-inflammatory drug-associated upper gastrointestinal lesions in rheumatoid arthritis patients. Relationships to gastric histology, Helicobacter pylori infection, and other risk factors for peptic ulcer.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

21 January 2018

Medication toxicity among patients with ankylosing spondylitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

21 January 2018

Long term safety of methotrexate in routine clinical care: discontinuation is unusual and rarely the result of laboratory abnormalities.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

21 January 2018

Methotrexate drug interactions in the treatment of rheumatoid arthritis: a systematic review

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

21 January 2018

Treatment of rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

21 January 2018

Use of simple analgesics in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

21 January 2018

Grading quality of evidence and strength of recommendations

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

21 January 2018

Methotrexate therapy in rheumatoid arthritis: 15 years experience

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

21 January 2018

Methotrexate monotherapy versus methotrexate combination therapy with non-biologic disease modifying anti-rheumatic drugs for rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

21 January 2018

Rational use of new and existing disease-modifying agents in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

21 January 2018

Methotrexate pulmonary toxicity

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

21 January 2018

The effect of folic acid supplementation on the toxicity of low-dose methotrexate in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

21 January 2018

Modes of action of aspirin-like drugs: salicylates inhibit erk activation and integrin-dependent neutrophil adhesion.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

21 January 2018

Methotrexate for rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

21 January 2018

Effects of low-to-high doses of aspirin on platelet aggregability and metabolites of thromboxane A2 and prostacyclin

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

21 January 2018

Better efficacy of methotrexate given by intramuscular injection than orally in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

21 January 2018

Paracetamol versus nonsteroidal anti-inflammatory drugs for rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

21 January 2018

Toxicity of methotrexate compared with azathioprine in the treatment of rheumatoid arthritis. A case-control study of 131 patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Response to methotrexate treatment is associated with reduced mortality in patients with severe rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized, double-blind, placebo controlled trial of low-dose pulse methotrexate in psoriatic arthritis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of low-dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

The safety and efficacy of the use of methotrexate in long-term therapy for rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Biliary elimination of low-dose methotrexate in humans

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Aspirin alters methotrexate disposition in rheumatoid arthritis patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Methotrexate for rheumatoid arthritis. Suggested guidelines for monitoring liver toxicity. American College of Rheumatology

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of the clinical efficacy and safety of subcutaneous versus oral administration of methotrexate in patients with active rheumatoid arthritis: results of a six-month, multicenter, randomized, double-blind, controlled, phase IV trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

The effects of non-steroidal anti-inflammatory drugs on the disposition of methotrexate in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term experience with low dose methotrexate in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Experience with low-dose methotrexate: toxicity, tolerability and effect on conventional patterns of drug therapy for inflammatory arthritis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Durability of treatment with methotrexate in Venezuelan patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and tolerability of valdecoxib in treating the signs and symptoms of severe rheumatoid arthritis: a 12-week, multicenter, randomized, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of low-dose methotrexate in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Leflunomide versus methotrexate: a comparison of the European and American experience.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Autoimmune and Chronic Inflammatory Disorders and Risk of Non-Hodgkin Lymphoma by Subtype

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

The synergistic effect of salicylates on methotrexate toxicity

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment-induced stable, moderate reduction in blood cell counts correlate to disease control in early rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008872.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/14651858.CD008872.PUB2

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PubMed publication ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q24235194&oldid=1578927027"